XOMA Corporation (XOMAO)
NASDAQ·Healthcare·Biotechnology
$25.19
+0.08%
Mkt Cap $304.05M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $11.05M | $13.76M | +24.50% | -$0.11 | $0.26 | +326.99% | — | — |
| Q4 2025 Nov 12, 2025 | $11.47M | $9.35M | -18.46% | -$0.04 | $0.78 | +2037.50% | — | — |
| Q3 2025 Aug 15, 2025 | $11.00M | $5.38M | -51.10% | -$0.15 | $0.52 | +444.67% | — | — |
| Q2 2025 May 13, 2025 | $7.07M | $15.91M | +125.22% | -$0.24 | $0.20 | +183.21% | — | — |
| Q1 2025 Mar 17, 2025 | $8.75M | $8.71M | -0.37% | -$0.29 | -$0.33 | -16.48% | — | — |
| Q4 2024 Nov 7, 2024 | $8.75M | $7.20M | -17.72% | — | -$1.47 | — | — | — |
| Q3 2024 Aug 13, 2024 | — | $11.09M | — | — | $0.92 | — | — | — |
| Q2 2024 May 9, 2024 | — | $1.49M | — | — | -$0.74 | — | — | — |
| Q1 2024 Mar 8, 2024 | — | $1.83M | — | — | -$1.75 | — | — | — |
| Q1 2024 Mar 6, 2024 | — | $830.00K | — | — | -$0.48 | — | — | — |
| Q3 2023 Aug 8, 2023 | — | $1.66M | — | — | -$0.47 | — | — | — |
| Q2 2023 May 9, 2023 | — | $437.00K | — | — | -$1.55 | — | — | — |
| Q1 2023 Mar 9, 2023 | — | $1.49M | — | — | -$0.52 | — | — | — |
| Q4 2022 Nov 3, 2022 | — | $451.00K | — | — | -$0.35 | — | — | — |
| Q3 2022 Aug 4, 2022 | — | $983.00K | — | — | -$0.40 | — | — | — |
| Q2 2022 May 5, 2022 | — | $3.11M | — | — | -$0.22 | — | — | — |
| Q1 2022 Mar 8, 2022 | — | $35.94M | — | — | $2.51 | — | — | — |
| Q4 2021 Nov 4, 2021 | — | $940.00K | — | — | -$0.39 | — | — | — |
| Q3 2021 Aug 5, 2021 | — | $901.00K | — | — | -$0.20 | — | — | — |
| Q2 2021 May 6, 2021 | — | $375.00K | — | — | -$0.65 | — | — | — |